mdlinx mdlinx
Latest (139) Full Text Articles (6313) Focus on Leukemia/lymphoma Article Summary

Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets and prognostic impact Full Text
Clinical Cancer Research, 06/01/2012

Barros MHM et al. – Macrophage composition in pediatric cHL is distinct from adults. Functional status of macrophages and their value as prognostic indicators in pediatric cHL may depend on EBV status.

Methods

  • We analyzed the number of macrophages and dendritic cells (DCs) in the tumor microenvironment of pediatric cHL by immunohistochemistry (IHC).
  • Results were analyzed in context of age, histological characteristics, EBV-status, clinical follow-up and our previous study of T-cell populations in these cases.

Results
  • 100 cHL cases were studied, including 69% nodular sclerosis (NS) and 23% mixed cellularity (MC) cases. 44.8% of cases were EBV-positive.
  • Patients
  • In comparison to NS, MC was characterized by higher numbers of CD14+, (P= 0.003) and CD163+ cells (P= 0.027).
  • EBV+ cases exhibited higher numbers of CD14+ (P< 0.0005), CD68+ (P= 0.005) and CD163+ cells (P= 0.02).
  • CD68-positive cells did not display an effect on outcome.
  • Worse overall survival was observed in cases with CD163/CD8 ratio >/=2 (P= 0.007).
  • High numbers of CD163+ cells were associated with worse progression-free survival (PFS) (P= 0.015).
  • Furthermore, high numbers of CD163+ and Granzyme B+ cells were associated with worse PFS in EBV-negative (P= 0.005) but not in EBV-positive cases.

► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close